Homozygous mutation in MFSD2A, encoding a lysolipid transporter for docosahexanoic acid, is associated with microcephaly and hypomyelination

Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis

(2017) Benjamin J. Andreone et al.   NEURON

Structural Insights into the Transport Mechanism of the Human Sodium-dependent Lysophosphatidylcholine Transporter MFSD2A

(2016) Debra Q. Y. Quek et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Serine biosynthesis and transport defects

(2016) Ayman W. El-Hattab   MOLECULAR GENETICS AND METABOLISM

Solute Carriers in the Blood–Brain Barier: Safety in Abundance

(2016) Katarzyna A. Nałęcz   NEUROCHEMICAL RESEARCH

A homozygous mutation inSLC1A4in siblings with severe intellectual disability and microcephaly

(2015) M. Srour et al.   CLINICAL GENETICS

SLC1A4mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum

(2015) G. Heimer et al.   CLINICAL GENETICS

Mutations inSLC1A4, encoding the brain serine transporter, are associated with developmental delay, microcephaly and hypomyelination

(2015) Nadirah Damseh et al.   JOURNAL OF MEDICAL GENETICS

Case definition and classification of leukodystrophies and leukoencephalopathies

(2015) Adeline Vanderver et al.   MOLECULAR GENETICS AND METABOLISM

A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome

(2015) Vafa Alakbarzade et al.   NATURE GENETICS

Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome

(2015) Alicia Guemez-Gamboa et al.   NATURE GENETICS

Essential role of docosahexaenoic acid towards development of a smarter brain

(2015) Kusumika Gharami et al.   NEUROCHEMISTRY INTERNATIONAL

Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases

(2014) Mary Dunbar et al.   MOLECULAR GENETICS AND METABOLISM

Mfsd2a is critical for the formation and function of the blood–brain barrier

(2014) Ayal Ben-Zvi et al.   NATURE

Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid

(2014) Long N. Nguyen et al.   NATURE

Blood-Brain Barrier: A Dual Life of MFSD2A?

(2014) Zhen Zhao et al.   NEURON

Phenotype and genotype in 101 males with X-linked creatine transporter deficiency

(2013) J M van de Kamp et al.   JOURNAL OF MEDICAL GENETICS

The major facilitator superfamily (MFS) revisited

(2012) Vamsee S. Reddy et al.   FEBS Journal

Major Facilitator Superfamily Domain-Containing Protein 2a (MFSD2A) Has Roles in Body Growth, Motor Function, and Lipid Metabolism

(2012) Justin H. Berger et al.   PLoS One

Mutations in FLVCR2 Are Associated with Proliferative Vasculopathy and Hydranencephaly-Hydrocephaly Syndrome (Fowler Syndrome)

(2010) Esther Meyer et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Rapid Context-Dependent Ligand Desolvation in Molecular Docking

(2010) Michael M. Mysinger et al.   Journal of Chemical Information and Modeling

Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid

(2009) C. He et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Improved prediction of protein side-chain conformations with SCWRL4

(2009) Georgii G. Krivov et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

(2008) Berislav V. Zlokovic   NEURON